AstraZeneca has decided to temporarily hold off Phase 3 testing for the Coronavirus vaccine due to a suspected adverse reaction in a participant in the United Kingdom. The pause will enable the pharmaceutical company to do a standard review of its safety data. AstraZeneca’s spokesperson said that the pause is “a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
Fox News: AstraZeneca is “working to expedite the review of the single event to minimize any potential impact on the trial timeline.”
According to Fox News AstraZeneca will put an experimental coronavirus vaccine study on hold in America after a participant in the United Kingdom faced an apparent serious adverse reaction, according to a report.
A suspected serious adverse reaction includes symptoms that require hospitalization, life-threatening illness and even death.
The New York Times, citing a person familiar with the situation, said an individual in the study came down with transverse myelitis, which the paper described as an inflammatory syndrome in the spinal cord. The paper said it was not clear if there was a connection to the vaccine.
